These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 36980187)
21. The present roles and future perspectives of Interleukin-6 in biliary tract cancer. Zhou M; Na R; Lai S; Guo Y; Shi J; Nie J; Zhang S; Wang Y; Zheng T Cytokine; 2023 Sep; 169():156271. PubMed ID: 37331095 [TBL] [Abstract][Full Text] [Related]
22. The pathways of genetic transformation in cholangiocarcinogenesis. Serafini FM; Radvinsky D Cancer Genet; 2016 Dec; 209(12):554-558. PubMed ID: 27720541 [TBL] [Abstract][Full Text] [Related]
23. Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma. Zimmer CL; Filipovic I; Cornillet M; O'Rourke CJ; Berglin L; Jansson H; Sun D; Strauss O; Hertwig L; Johansson H; von Seth E; Sparrelid E; Dias J; Glaumann H; Melum E; Ellis EC; Sandberg JK; Andersen JB; Bergquist A; Björkström NK Hepatology; 2022 May; 75(5):1154-1168. PubMed ID: 34719787 [TBL] [Abstract][Full Text] [Related]
24. [Gallbladder and bile duct carcinoma. Biology and pathology]. Tannapfel A; Wittekind C Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242 [TBL] [Abstract][Full Text] [Related]
25. Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma. Job S; Rapoud D; Dos Santos A; Gonzalez P; Desterke C; Pascal G; Elarouci N; Ayadi M; Adam R; Azoulay D; Castaing D; Vibert E; Cherqui D; Samuel D; Sa Cuhna A; Marchio A; Pineau P; Guettier C; de Reyniès A; Faivre J Hepatology; 2020 Sep; 72(3):965-981. PubMed ID: 31875970 [TBL] [Abstract][Full Text] [Related]
26. Matricellular proteins in intrahepatic cholangiocarcinoma. Sirica AE Adv Cancer Res; 2022; 156():249-281. PubMed ID: 35961702 [TBL] [Abstract][Full Text] [Related]
27. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase. Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870 [TBL] [Abstract][Full Text] [Related]
32. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Sirica AE Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):44-54. PubMed ID: 22143274 [TBL] [Abstract][Full Text] [Related]
33. Pathologic classification of cholangiocarcinoma: New concepts. Nakanuma Y; Kakuda Y Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428 [TBL] [Abstract][Full Text] [Related]
34. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma. Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957 [TBL] [Abstract][Full Text] [Related]
35. Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma. Zhong YJ; Luo XM; Liu F; He ZQ; Yang SQ; Ma WJ; Wang JK; Dai YS; Zou RQ; Hu YF; Lv TR; Li FY; Hu HJ J Transl Med; 2024 May; 22(1):422. PubMed ID: 38702814 [TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions. Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641 [TBL] [Abstract][Full Text] [Related]
37. Novel insights into molecular and immune subtypes of biliary tract cancers. Bramel ER; Sia D Adv Cancer Res; 2022; 156():167-199. PubMed ID: 35961699 [TBL] [Abstract][Full Text] [Related]